TSXV:LBL.H - Post by User
Post by
GekkoInvestor19on May 11, 2020 1:53pm
204 Views
Post# 31012970
Email Correspondence w/ Guy Cook Today
Email Correspondence w/ Guy Cook Today Mon, May 11 at 10:47 AM
Good morning Mr. Cook,
Just a few questions regarding this mornings news release:
Do you expect there to be similar hurdles outside of the hospital setting, or was the IRB the biggest hurdle?
Which countries outside of the USA are the additional studies taking place?
The news release says the company continues to enroll patients in Montana... how many patients have been enrolled?
Is your target goal still 10 patients before you release the results?
Have you tested any Covid 19 patients with AmnioBoost as of yet, or has recruitment been incredibly challenging?
Thank you
__________________________________________________________________________________________________________________
Guy Cook <gcook@latticebiologics.com>
To:
Mon, May 11 at 1:45 PM
Hi
See answers below:
Do you expect there to be similar hurdles outside of the hospital setting, or was the IRB the biggest hurdle?
We think by moving to the RRT office will make it significantly easier to treat patients. The CRO's recommended the change, specifically if we don't intend to treat patients already on ventilators.
Which countries outside of the USA are the additional studies taking place?
Expected to be Australia and Romania, still finalizing quotes.
The news release says the company continues to enroll patients in Montana... how many patients have been enrolled?
We have 4 patients slated for MT right now, but we expect to enroll more outside of MT. A phase 2 study would be ~ 300 patients.
Is your target goal still 10 patients before you release the results?
We need to enroll all 10, and then 2-4 weeks for the results.
Have you tested any Covid 19 patients with AmnioBoost as of yet, or has recruitment been incredibly challenging?
Yes, positive results, recruitment is challenging in MT, which is where we are licensed for our physicians.
Guy